Kimberly-Clark (NASDAQ:KMB) leadership outlined its “Powering Care” strategy and the company’s preparations for its pending ...

Gross margin reflects one-time costs of approximately $1.9 million, or 1% for the full-year 2025, related to the FDA BLA approval of Avance ®, of which 67% are non-cash and relate to the vesting of ...

The Tribunal found that denial of foreign tax credit during return processing was improper where Form 67 and the return were filed together. The Assessing Officer was directed to verify and allow ...

The Court held that mere recommendation for promotion does not create an accrued right when no D.P.C. or select list was prepared. Since the cadre was abolished before completion of the process, ...